These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37355940)

  • 81. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mosaic capillaroscopic findings in systemic sclerosis.
    Lambova SN; Müller-Ladner U
    Wien Med Wochenschr; 2018 Jun; 168(9-10):248-249. PubMed ID: 29392502
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Capillaroscopy changes are associated with disease progression in patients with early systemic sclerosis: A prospective study.
    Zumstein Camargo C; Kayser C
    Int J Rheum Dis; 2019 Jul; 22(7):1319-1326. PubMed ID: 31050209
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
    Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
    J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
    De Angelis R; Ferri C; Giuggioli D; Bajocchi G; Dagna L; Bellando-Randone S; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Lepri G; Girelli F; Riccieri V; Zanatta E; Bosello SL; Cavazzana I; Ingegnoli F; De Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano AM; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Cipolletta E; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Di Vico C; Gigante A; Pellagrino G; Pigatto E; Lazzaroni MG; Franceschini F; Generali E; Mennillo G; Barsotti S; Mariano GP; Furini F; Vultaggio L; Parisi S; Peroni CL; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Guiducci S; Doria A; Salvarani C; Iannone F; Matucci-Cerinic M;
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36868782
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antinuclear antibody-negative systemic sclerosis.
    Salazar GA; Assassi S; Wigley F; Hummers L; Varga J; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Taillefer SS; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Molitor JA; Fritzler MJ; Segal BM; Al-Kassab F; Perry M; Yang J; Zamanian S; Reveille JD; Arnett FC; Pedroza C; Mayes MD
    Semin Arthritis Rheum; 2015 Jun; 44(6):680-6. PubMed ID: 25578738
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Characteristics of patients with systemic sclerosis living in Qatar.
    Alam F; Abdulaziz HM; Ul Haq I; Mahdy SM; Mohammed Siam AR; Chandra P; Al Emadi S
    Qatar Med J; 2019; 2019(3):16. PubMed ID: 31903322
    [No Abstract]   [Full Text] [Related]  

  • 88. Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.
    Moinzadeh P; Nihtyanova SI; Howell K; Ong VH; Denton CP
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):249-55. PubMed ID: 22711501
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.
    Sujau I; Ng CT; Sthaneshwar P; Sockalingam S; Cheah TE; Yahya F; Jasmin R
    Int J Rheum Dis; 2015 May; 18(4):459-65. PubMed ID: 24618222
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.
    Volkmann ER; Furst DE
    Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry.
    Denton CP; Krieg T; Guillevin L; Schwierin B; Rosenberg D; Silkey M; Zultak M; Matucci-Cerinic M;
    Ann Rheum Dis; 2012 May; 71(5):718-21. PubMed ID: 22247218
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
    Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
    J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Relationship between type of skin lesions and nailfold capillaroscopy pattern in mixed connective tissue disease.
    Felis-Giemza A; Ornowska S; Haładyj E; Czuszyńska Z; Olesińska M
    Clin Rheumatol; 2022 Jan; 41(1):281-288. PubMed ID: 34370129
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.
    Foocharoen C; Peansukwech U; Mahakkanukrauh A; Suwannaroj S; Pongkulkiat P; Khamphiw P; Nanagara R
    Int J Rheum Dis; 2020 Jul; 23(7):945-957. PubMed ID: 32420701
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis.
    Mihai C; Smith V; Dobrota R; Gheorghiu AM; Cutolo M; Distler O
    Microvasc Res; 2018 Jul; 118():113-120. PubMed ID: 29544760
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease?
    Blaja E; Jordan S; Mihai CM; Dobrota R; Becker MO; Maurer B; Matucci-Cerinic M; Distler O
    J Rheumatol; 2021 Jan; 48(1):82-86. PubMed ID: 32173655
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.
    Correa MJ; Andrade LE; Kayser C
    Arthritis Res Ther; 2010; 12(4):R157. PubMed ID: 20696074
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis.
    Szucs G; Szekanecz Z; Aszalos Z; Gesztelyi R; Zsuga J; Szodoray P; Kemeny-Beke A
    Ocul Immunol Inflamm; 2021 Jan; 29(1):81-89. PubMed ID: 31577461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.